Yamaoka K - Search Results

1

An immunomodulating protein, Ling Zhi-8 (LZ-8) prevents insulitis in non-obese diabetic mice.

Kino K, Mizumoto K, Sone T, Yamaji T, Watanabe J, Yamashita A, Yamaoka K, Shimizu K, Ko K, Tsunoo H. Kino K, et al. Among authors: yamaoka k. Diabetologia. 1990 Dec;33(12):713-8. doi: 10.1007/BF00400340. Diabetologia. 1990. PMID: 2073984

2

Isolation and characterization of a new immunomodulatory protein, ling zhi-8 (LZ-8), from Ganoderma lucidium.

Kino K, Yamashita A, Yamaoka K, Watanabe J, Tanaka S, Ko K, Shimizu K, Tsunoo H. Kino K, et al. Among authors: yamaoka k. J Biol Chem. 1989 Jan 5;264(1):472-8. J Biol Chem. 1989. PMID: 2909532 Free article.

3

Induction of metallothionein synthesis in Menkes' and normal lymphoblastoid cells is controlled by the level of intracellular copper.

Sone T, Yamaoka K, Minami Y, Tsunoo H. Sone T, et al. Among authors: yamaoka k. J Biol Chem. 1987 Apr 25;262(12):5878-85. J Biol Chem. 1987. PMID: 3494730 Free article.

4

Transport characteristics of ebastine and its metabolites across human intestinal epithelial Caco-2 cell monolayers.

Imamura Y, Shimizu K, Yamashita F, Yamaoka K, Takakura Y, Hashida M. Imamura Y, et al. Among authors: yamaoka k. Biol Pharm Bull. 2001 Aug;24(8):930-4. doi: 10.1248/bpb.24.930. Biol Pharm Bull. 2001. PMID: 11510488 Free article.

5

Effect of interferons on P-glycoprotein-mediated rhodamine-123 efflux in cultured rat hepatocytes.

Akazawa Y, Kawaguchi H, Funahashi M, Watanabe Y, Yamaoka K, Hashida M, Takakura Y. Akazawa Y, et al. Among authors: yamaoka k. J Pharm Sci. 2002 Oct;91(10):2110-5. doi: 10.1002/jps.10199. J Pharm Sci. 2002. PMID: 12226838

6

Hepatic uptake and gene expression mechanisms following intravenous administration of plasmid DNA by conventional and hydrodynamics-based procedures.

Kobayashi N, Kuramoto T, Yamaoka K, Hashida M, Takakura Y. Kobayashi N, et al. Among authors: yamaoka k. J Pharmacol Exp Ther. 2001 Jun;297(3):853-60. J Pharmacol Exp Ther. 2001. PMID: 11356904

7

Pharmacokinetic analysis of in vivo disposition of succinylated proteins targeted to liver nonparenchymal cells via scavenger receptors: importance of molecular size and negative charge density for in vivo recognition by receptors.

Yamasaki Y, Sumimoto K, Nishikawa M, Yamashita F, Yamaoka K, Hashida M, Takakura Y. Yamasaki Y, et al. Among authors: yamaoka k. J Pharmacol Exp Ther. 2002 May;301(2):467-77. doi: 10.1124/jpet.301.2.467. J Pharmacol Exp Ther. 2002. PMID: 11961045

8

Analysis methods and recent advances in nonlinear pharmacokinetics from in vitro through in loci to in vivo.

Yamaoka K, Takakura Y. Yamaoka K, et al. Drug Metab Pharmacokinet. 2004 Dec;19(6):397-406. doi: 10.2133/dmpk.19.397. Drug Metab Pharmacokinet. 2004. PMID: 15681893 Free article. Review.

9

Quantitative and temporal analysis of gene silencing in tumor cells induced by small interfering RNA or short hairpin RNA expressed from plasmid vectors.

Takahashi Y, Yamaoka K, Nishikawa M, Takakura Y. Takahashi Y, et al. Among authors: yamaoka k. J Pharm Sci. 2009 Jan;98(1):74-80. doi: 10.1002/jps.21398. J Pharm Sci. 2009. PMID: 18452181

10

Efficient scavenger receptor-mediated hepatic targeting of proteins by introduction of negative charges on the proteins by aconitylation: the influence of charge density and size of the proteins molecules.

Yamasaki Y, Hisazumi J, Yamaoka K, Takakura Y. Yamasaki Y, et al. Among authors: yamaoka k. Eur J Pharm Sci. 2003 Apr;18(5):305-12. doi: 10.1016/s0928-0987(03)00021-6. Eur J Pharm Sci. 2003. PMID: 12694882

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

976 results

Search Page

Filters